Meradoc Healthtech Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 8.78 Cr
as on 13-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 124240.36%
(FY 2023)
- Profit -136.89%
(FY 2023)
- Ebitda -123.35%
(FY 2023)
- Net Worth -42.74%
(FY 2023)
- Total Assets 13.11%
(FY 2023)
About Meradoc Healthtech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harsh Mahajan, Sudhir Mathur, Chandra Mishra, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85100DL2021PTC381293
- Company No.
381293
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Meradoc Healthtech?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Mathur  | Director | 19-May-2021 | Current |
| Himanshu Sikka | Director | 19-May-2021 | Current |
| Arvinder Gujral | Director | 31-Mar-2022 | Current |
| Harsh Mahajan | Director | 24-Nov-2021 | Current |
| Chandra Mishra | Director | 24-Aug-2022 | Current |
| Eshaan Singh | Director | 19-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Meradoc Healthtech.
Meradoc Healthtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 124240.36% increase. The company also saw a substantial fall in profitability, with a 136.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meradoc Healthtech?
In 2023, Meradoc Healthtech had a promoter holding of 95.62% and a public holding of 4.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meradoc Healthtech?
Meradoc Healthtech has a workforce of 25 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meradoc Healthtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meradoc Healthtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
